U.S. Bancorp’s USB fourth-quarter 2024 adjusted earnings per share (excluding the impacts of notable items) of $1.07 beat the ...
With a market cap of $77.3 billion, Regeneron Pharmaceuticals, Inc. (REGN) is a leading biotechnology company dedicated to ...